Sharapova positive test sparks renewed vigilance in New Zealand

  • Tennis
  • Monday, 04 Apr 2016

Mildronate (Meldonium) medication capsules are pictured in the production plant of the Grindeks pharmaceutical company in Riga, Latvia, in this November 23, 2010 file photo. Several major U.S. sports leagues are pushing to add the drug that led to a positive test for Russian tennis star Maria Sharapova to their banned list, but in many cases they will need player approval before they can hit that goal. Sharapova, who last week revealed she had tested positive for the banned drug meldonium at the Australian Open in January, is facing suspension of up to four years by the International Tennis Federation. REUTERS/Ints Kalnins/Files

AUCKLAND (Reuters) - Athletes in New Zealand have become more vigilant about the medication and supplements they take in the wake of Russian tennis player Maria Sharapova's positive test, Drug Free Sports New Zealand (DFSNZ) said on Monday.

The five-times grand slam champion announced in March she had tested positive for the banned substance meldonium at the Australian Open in January.

Sharapova said she had been unaware that it had been banned by the World Anti-Doping Agency (WADA) from Jan. 1. Since then, more than 100 athletes across a variety of sports have been found to have used it.

"It is sad that a famous athlete has been caught out in this way, but the good outcome for us is that it has helped get our message across to athletes that they need to check all medications and supplements carefully," Drug Free Sports New Zealand (DFSNZ) Chief Executive Graeme Steel said on Monday.

DFSNZ is a government body that implements the World Anti-Doping Code in New Zealand.

Athletes were using the organisation's website and telephone and email channels to check everything from cold sore cream to asthma medication, he added.

DFSNZ said in the two weeks prior to Sharapova's announcement they had received 961 queries about medication and another 339 about supplements through the website.

In the two weeks after the announcement, those figures had more than doubled to 1,982 queries about medication and 581 for supplements.

The request rate for information through DFSNZ's text and email service had also significantly increased they added.

A spokesperson told Reuters they typically received only three or four requests a day via email and text messaging, but that had increased to more than 20 per day.

"We've invested a lot of resources into ensuring that our athletes, parents and support personnel here in New Zealand have access to the most up-to-date information on banned substances and supplements," Steel added.

"It's about education and access to information so that athletes aren't caught unintentionally taking a banned substance, which could ultimately affect their health and their careers."

(Reporting by Greg Stutchbury in Wellington; Editing by Peter Rutherford)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

Did you find this article insightful?


Next In Tennis

Pliskova appoints Bajin as new coach for 2021 season
Organisers await government nod to allow players to train in Australian Open quarantine
Nadal leads tennis world in paying respect to Maradona
Murray joins calls for domestic abuse policy in tennis
Players must be able to train ahead of Australian Open: Medvedev
Australian Open delay 'most likely', says state minister
Medvedev excited to be part of new men's rivalries
Medvedev storms back to beat Thiem and claim ATP Finals title
Koolhof and Mektic claim ATP Finals doubles title
Medvedev fights off Nadal to set up ATP Finals showdown with Thiem

Stories You'll Enjoy